Item 2.02 Results of Operations and Financial Condition. The information disclosed under the heading “ Cash, Cash Equivalents and Available-for-SaleSecurities as of December 31, 2024” under Item 8.01 of this Current Report on Form8-Kis herein incorporated by reference.

Item 8.01 Other Events.

Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit Description No. ───────────────────────────────────────────────────────────────────────────── 99.1 Solid Biosciences Inc. Presentation February 2025. 104 Cover Page Interactive Data File (formatted as Inline XBRL). SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SOLID BIOSCIENCES INC. Date: February 18, 2025 By: /s/ Alexander Cumbo Name: Alexander Cumbo Title: Chief Executive Officer